Anagnostics hybcell technology

COMPANION
DIAGNOSTICS

COST EFFICIENT – SENSITIVE – SPECIFIC

Early and mutant-specific results with constant costs even for a single sample.

more Info

DRUGS OF ABUSE SCREENING

COMPREHENSIVE – FAST – SIMPLE

Screening of a broad range of drugs and drug groups (>20) in less than 20 minutes from urine or serum.

more Info

DETECTION OF
PATHOGENS

INTEGRATED SEPSIS DIAGNOSTICS
COMPREHENSIVE – FAST – MINIMUM SAMPLE

Highly sensitive detection of pathogens from whole blood in only 4 hours.

more Info

INFLAMMATION
MONITORING

INTEGRATED SEPSIS DIAGNOSTICS
COMPREHENSIVE – FAST – MINIMUM SAMPLE

A range of markers from only 100µL plasma in around 20min are basis of an inflammation monitoring.

more Info

INTEGRATED SEPSIS DIAGNOSTICS

Sepsis is one of the most common causes of death, with someone dying every three seconds. It is more common than death from stroke or heart attacks in the general population. The number of sepsis hospitalisations doubled in the US between 2000 and 2008. Sepsis represents a huge burden on healthcare providers, with about 1 in 10 patients in intensive care units suffering from sepsis. The cost of sepsis hospitalisations in the US was $14.6 billion in 2008.

Anagnostics’ Integrated Sepsis Diagnostics aids initial sepsis diagnosis, selection of optimal anti-infective therapy and assists monitoring of patient responses to the therapy. The company's hybserver software enables integration of all data on a patient by patient basis over time (trending).
Meet us

Meet us next at 'Fruehjahrstagung der Oesterreichischen Gesellschaft für Pathologie / Oesterreichische Abteilung der IAP'.

Anagnostics takes part at the "Fruehjahrstagung der Oesterreichischen Gesellschaft für Pathologie / Oesterreichische Abteilung der IAP" taking place from 5th to 7th of March 2015 in Vienna (Austria). Make an appointment using info@anagnostics.com!

+++News Ticker+++

 

 

 

In collaboration with the hospital of Wels (Austria) the successful use of hybcell Pathogen DNA is demonstrated in clinical practice and compared to existing diagnostic technologies. The link to the poster can be found here.